Response line publications

3 07, 2018

Federico Pessina et. al, Is surgical resection useful in elderly newly diagnosed glioblastoma patients? Outcome evaluation and prognostic factors assessment

Diatech Pharmacogenetics2018-07-03T14:01:24+02:00

2 07, 2018

Laura Boldrini et. al, Expression profiling and microRNA regulation of the LKB1 pathway in young and aged lung adenocarcinoma patients

Diatech Pharmacogenetics2018-07-02T14:06:28+02:00

14 05, 2018

Eric Van Cutsem et. al, Phase I/II trial of pimasertib plus gemcitabine in patients with metastatic pancreatic cancer.

Diatech Pharmacogenetics2018-05-14T15:40:11+02:00

9 03, 2018

Lorena Gurrieri et. al, MGMT pyrosequencing-based cut-off methylation level and clinical outcome in patients with glioblastoma multiforme”

Diatech Pharmacogenetics2018-04-12T15:39:06+02:00

12 01, 2018

Serena Trubini et al., Novel BRAF mutation in melanoma: A case report

Diatech Pharmacogenetics2018-02-01T13:12:11+01:00

27 12, 2017

Thibaut Kritter et. al, Radiomic Biomarkers Helps to Better Predict Progression Free Survival of Gliomas

Diatech Pharmacogenetics2017-12-27T13:53:35+01:00

4 12, 2017

Susanna Cappia et. al, Detection of EGFR mutations in archival lung cancer samples by pyrosequencing

Diatech Pharmacogenetics2017-12-04T16:12:04+01:00

4 12, 2017

Giovanna De Maglio et. al, Sequenziamento mediante pyrosequencing: un’analisi rapida e sensibile per la determinazione delle mutazioni di EGFR nel carcinoma polmonare non a piccole cellule

Diatech Pharmacogenetics2017-12-04T16:06:50+01:00

4 12, 2017

G Aggarwal et. al, SOX2 Immunoexpression in High-Grade Gliomas: Potential Marker for Targeted Therapy

Diatech Pharmacogenetics2018-01-30T10:38:34+01:00

18 09, 2017

Elena Ongaro et al., 552PMutational status and metastatic patteRn in a cohort Of ADvanced colorectal cancer (aCRC) patients (pts): The ROAD study

Diatech Pharmacogenetics2020-01-22T09:23:08+01:00

Previous 345 Next